{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:15:56Z","timestamp":1794208556759,"version":"4.8.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ijantimicag.2020.106019","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T21:13:03Z","timestamp":1589577183000},"page":"106019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Co-occurrence of aminoglycoside and \u03b2-lactam resistance mechanisms in aminoglycoside- non-susceptible Escherichia coli isolated in the Zurich area, Switzerland"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6946-9868","authenticated-orcid":false,"given":"Elias","family":"Bodendoerfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3076-1735","authenticated-orcid":false,"given":"Martina","family":"Marchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Imkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Courvalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik C.","family":"B\u00f6ttger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijantimicag.2020.106019_bib0001","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist Updat"},{"issue":"2","key":"10.1016\/j.ijantimicag.2020.106019_bib0002","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijantimicag.2015.03.008","article-title":"Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin\/clavulanic acid isolated in Spain","volume":"46","author":"Fern\u00e1ndez-Mart\u00ednez","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.ijantimicag.2020.106019_bib0003","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/mdr.2017.0102","article-title":"Prevalence of aminoglycoside-modifying enzymes in Escherichia coli and Klebsiella pneumoniae producing extended spectrum \u03b2-lactamases collected in two multicenter studies in spain","volume":"24","author":"Fern\u00e1ndez-Mart\u00ednez","year":"2018","journal-title":"Microb Drug Resist"},{"issue":"1","key":"10.1016\/j.ijantimicag.2020.106019_bib0004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.advms.2017.05.004","article-title":"Genetic basis of enzymatic resistance of E. coli to aminoglycosides","volume":"63","author":"Ojdana","year":"2018","journal-title":"Adv Med Sci"},{"issue":"5","key":"10.1016\/j.ijantimicag.2020.106019_bib0005","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000361011","article-title":"High prevalence of cross-resistance to aminoglycosides in fluoroquinolone-resistant Escherichia coli clinical isolates","volume":"59","author":"Tsukamoto","year":"2013","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2020.106019_bib0006","doi-asserted-by":"crossref","unstructured":"Courvalin P, LeClercq R, Rice LB. Antibiogram: American Society of Microbiology, 2010.","DOI":"10.1128\/9781555814960"},{"issue":"2","key":"10.1016\/j.ijantimicag.2020.106019_bib0007","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.idc.2016.02.011","article-title":"Aminoglycoside resistance: The emergence of acquired 16S ribosomal RNA methyltransferases","volume":"30","author":"Doi","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijantimicag.2020.106019_bib0008","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ebiom.2019.07.020","article-title":"Population-based inference of aminoglycoside resistance mechanisms in Escherichia coli","volume":"46","author":"Mancini","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijantimicag.2020.106019_bib0009","first-page":"h6420","article-title":"Antibiotic resistance in Enterobacteriaceae: Mechanisms and clinical implications","volume":"352","author":"Iredell","year":"2016"},{"issue":"3","key":"10.1016\/j.ijantimicag.2020.106019_bib0010","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/AAC.01009-09","article-title":"Updated functional classification of beta-lactamases","volume":"54","author":"Bush","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106019_bib0011","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/nyas.12023","article-title":"Proliferation and significance of clinically relevant \u03b2-lactamases","volume":"1277","author":"Bush","year":"2013","journal-title":"Annals N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.ijantimicag.2020.106019_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22122267","article-title":"Amikacin: Uses, resistance, and prospects for inhibition","volume":"22","author":"Ramirez","year":"2017","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"9","key":"10.1016\/j.ijantimicag.2020.106019_bib0013","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1128\/JCM.00576-11","article-title":"Improved performance of bacterium and yeast identification by a commercial matrix-assisted laser desorption ionization-time of flight mass spectrometry system in the clinical microbiology laboratory","volume":"49","author":"Haigh","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.ijantimicag.2020.106019_bib0014","doi-asserted-by":"crossref","first-page":"O255","DOI":"10.1111\/1469-0691.12373","article-title":"Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories","volume":"20","author":"Matuschek","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2020.106019_bib0015","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Data from the EUCAST MIC distribution website, last accessed 27-11-2019:http:\/\/www.eucast.org."},{"issue":"5","key":"10.1016\/j.ijantimicag.2020.106019_bib0016","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1469-0691.2006.01377.x","article-title":"Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values","volume":"12","author":"Turnidge","year":"2006","journal-title":"Clin Microb Infect"},{"key":"10.1016\/j.ijantimicag.2020.106019_bib0017","unstructured":"EUCAST. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and\/or epidemiological importance. Version 2.0 2017 [accessed 9 March 2018]."},{"issue":"8","key":"10.1016\/j.ijantimicag.2020.106019_bib0018","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/JCM.00404-11","article-title":"Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae","volume":"49","author":"Polsfuss","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.ijantimicag.2020.106019_bib0019","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1469-0691.2011.03737.x","article-title":"Evaluation of a diagnostic flow chart for detection and confirmation of extended spectrum \u03b2-lactamases (ESBL) in Enterobacteriaceae","volume":"18","author":"Polsfuss","year":"2012","journal-title":"Clin Microb Infect"},{"issue":"1","key":"10.1016\/j.ijantimicag.2020.106019_bib0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1128\/JCM.01692-14","article-title":"Evaluation of carbapenemase screening and confirmation tests with Enterobacteriaceae and development of a practical diagnostic algorithm","volume":"53","author":"Maurer","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.ijantimicag.2020.106019_bib0021","article-title":"ARIBA: Rapid antimicrobial resistance genotyping directly from sequencing reads","volume":"3","author":"Hunt","year":"2017","journal-title":"Microb Genom"},{"issue":"D1","key":"10.1016\/j.ijantimicag.2020.106019_bib0022","doi-asserted-by":"crossref","first-page":"D566","DOI":"10.1093\/nar\/gkw1004","article-title":"CARD 2017: Expansion and model-centric curation of the comprehensive antibiotic resistance database","volume":"45","author":"Jia","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.ijantimicag.2020.106019_bib0023","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1128\/AAC.01310-13","article-title":"ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes","volume":"58","author":"Gupta","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ijantimicag.2020.106019_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007261","article-title":"A genomic overview of the population structure of Salmonella","volume":"14","author":"Alikhan","year":"2018","journal-title":"PLoS Genetics"},{"key":"10.1016\/j.ijantimicag.2020.106019_bib0025","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria.https:\/\/www.R-project.org\/, 2019."},{"issue":"3","key":"10.1016\/j.ijantimicag.2020.106019_bib0026","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1128\/CMR.00047-06","article-title":"Setting and revising antibacterial susceptibility breakpoints","volume":"20","author":"Turnidge","year":"2007","journal-title":"Clin Microb Rev"},{"key":"10.1016\/j.ijantimicag.2020.106019_bib0027","unstructured":"Federal Office of Public Health and Federal Food Safety and Veterinary Office. Swiss antibiotic resistance report 2016.: Usage of antibiotics and occurrence of antibiotic resistance in bacteria from humans and animals in Switzerland. 2016(2016-OEG-30)."},{"key":"10.1016\/j.ijantimicag.2020.106019_bib0028","unstructured":"Federal Office of Public Health and Federal Food Safety and Veterinary Office. Swiss antibiotic resistance report 2018.: Usage of antibiotics and occurrence of antibiotic resistance in bacteria from humans and animals in Switzerland. 2018."},{"key":"10.1016\/j.ijantimicag.2020.106019_bib0029","doi-asserted-by":"crossref","unstructured":"The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2016. EFS2 2018;16(2):e0136052. 10.2903\/j.efsa.2018.5182.","DOI":"10.2903\/j.efsa.2018.5182"},{"key":"10.1016\/j.ijantimicag.2020.106019_bib0030","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fmicb.2015.00646","article-title":"Marked increase in incidence for bloodstream infections due to Escherichia coli, a side effect of previous antibiotic therapy in the elderly","volume":"6","author":"van der Mee-Marquet","year":"2015","journal-title":"Front Microb"},{"key":"10.1016\/j.ijantimicag.2020.106019_bib0031","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/IDR.S56984","article-title":"Mortality and molecular epidemiology associated with extended-spectrum \u03b2-lactamase production in Escherichia coli from bloodstream infection","volume":"7","author":"Leistner","year":"2014","journal-title":"Infect Drug Resist"},{"issue":"2","key":"10.1016\/j.ijantimicag.2020.106019_bib0032","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1089\/mdr.2012.0125","article-title":"Characterization of aminoglycoside-modifying enzymes in Enterobacteriaceae clinical strains and characterization of the plasmids implicated in their diffusion","volume":"19","author":"Mir\u00f3","year":"2013","journal-title":"Microb Drug Resist (Larchmont, N.Y.)"},{"issue":"1","key":"10.1016\/j.ijantimicag.2020.106019_bib0033","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.diagmicrobio.2013.10.001","article-title":"Increased prevalence of aminoglycoside resistance in clinical isolates of Escherichia coli and Klebsiella spp. in Norway is associated with the acquisition of AAC(3)-II and AAC(6\u2032)-Ib","volume":"78","author":"Haldorsen","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.ijantimicag.2020.106019_bib0034","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1128\/mr.57.1.138-163.1993","article-title":"Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes","volume":"57","author":"Shaw","year":"1993","journal-title":"Microbiol Rev"},{"issue":"2","key":"10.1016\/j.ijantimicag.2020.106019_bib0035","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/jac\/dky453","article-title":"OXA-1 \u03b2-lactamase and non-susceptibility to penicillin\/\u03b2-lactamase inhibitor combinations among ESBL-producing Escherichia coli","volume":"74","author":"Livermore","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.ijantimicag.2020.106019_bib0036","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1128\/CMR.00016-09","article-title":"Plasmid-mediated quinolone resistance: A multifaceted threat","volume":"22","author":"Strahilevitz","year":"2009","journal-title":"Clin Microb Rev"},{"issue":"6","key":"10.1016\/j.ijantimicag.2020.106019_bib0037","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1128\/AAC.01707-08","article-title":"Resistance plasmid families in Enterobacteriaceae","volume":"53","author":"Carattoli","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106019_bib0038","series-title":"Mandell, Douglas, and Bennett's Principles and practice of infectious diseases","author":"Bennett","year":"2010"},{"key":"10.1016\/j.ijantimicag.2020.106019_bib0039","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1469-0691.2000.tb02037.x","article-title":"Cooperative evolution of mechanisms of \u03b2-lactam resistance","volume":"6","author":"Medeiros","year":"2000","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.ijantimicag.2020.106019_bib0040","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/AAC.9.5.780","article-title":"Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae","volume":"9","author":"Lewis","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijantimicag.2020.106019_bib0041","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/AAC.13.3.484","article-title":"Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics","volume":"13","author":"George","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ijantimicag.2020.106019_bib0042","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/AAC.21.5.753","article-title":"In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents","volume":"21","author":"McNamara","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2020.106019_bib0043","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1093\/clinids\/24.Supplement_1.S46","article-title":"The most frequent aminoglycoside resistance mechanisms\u2013changes with time and geographic area: A reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups","volume":"24","author":"Miller","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ijantimicag.2020.106019_bib0044","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106019_bib0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijantimicag.2018.03.016","article-title":"High prevalence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacteriaceae in the UK & Ireland","volume":"52","author":"Taylor","year":"2018","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"10.1016\/j.ijantimicag.2020.106019_bib0046","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1128\/AAC.00572-10","article-title":"Synthesis and spectrum of the neoglycoside ACHN-490","volume":"54","author":"Aggen","year":"2010","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920301825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920301825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T19:32:54Z","timestamp":1735673574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920301825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0924857920301825"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106019","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-occurrence of aminoglycoside and \u03b2-lactam resistance mechanisms in aminoglycoside- non-susceptible Escherichia coli isolated in the Zurich area, Switzerland","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106019"}}